Navigation Links
Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock
Date:1/21/2008

Plan Ahead(TM) Test Offers Most Accurate Measurement of Women's Ovarian

Reserve

ATLANTA, Jan. 21 /PRNewswire/ -- Georgia Reproductive Specialists (GRS) today announced it will be the first IVF center in the southeast to offer the Repromedix Plan Ahead(TM) test, an innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors, including the measurement of ovary-related hormones AMH, Inhibin B, and FSH. The window of opportunity for a woman to have children by natural conception is dependent upon an adequate supply of eggs, which inevitably declines as a woman ages and her "biological clock ticks." Plan Ahead enables a woman to compare her estimated egg supply with the normal range expected for women of the same age.

The Plan Ahead Report provides valuable directional information about which women planning to have children after their late twenties should seek further advice from fertility experts to help ensure that those women with faster biological clocks can have the families they were hoping for.

"GRS has always incorporated the latest assisted reproductive technologies (ART) into our treatment plans to give our patients the best chance possible of having a baby, said Mark Perloe, M.D., Medical Director of Georgia Reproductive Specialists. "We strive to provide our patients with the most advanced testing and treatment options, so it is most appropriate that GRS is the first IVF center in the Southeast to offer the Plan Ahead test."

As women age, their fertility naturally declines, with increasingly fewer eggs available for fertilization. "With so many women delaying pregnancy until their 30s and 40s, women urgently need an accurate assessment of their egg supply," said Dr. Perloe. "And while we know that on average ovarian reserve begins a more rapid decline after age 35, it varies among women of the same age. The Plan Ahead test will provide women with
'/>"/>

SOURCE Repromedix
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice
2. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
3. Specialists in infectious disease and global health convene at Philadelphia meeting
4. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
5. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
6. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
7. Stemagen First to Create Cloned Human Embryos From Adult Cells
8. Peptimmune Announces First Close of Series D Private Financing
9. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
10. Pharmaxis Aridol Gains First Asian Approval
11. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  AsureQuality and Ubiquitome have agreed to collaborate ... food and primary production sectors. The collaboration will ... the Freedom4. AsureQuality provides quality assurance ... shelf for producers, processors and Competent Authorities around ... control and pest management and surveillance programmes. ...
(Date:7/29/2015)... ... July 29, 2015 , ... Brady (NYSE:BRC), ... GHS Label Guide . To align chemical container labeling with OSHA’s updated Hazard ... of label components, an example of an accurate label, and pictogram uses and ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company, is pleased to announce that the final design ... been locked.  Prototypes for industrial and regulatory testing ... application for CE mark clearance to market the ... 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Brady Announces a New GHS Label Guide 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5
... March 21, 2011 Insmed Incorporated (Nasdaq: INSMD), a ... Drug Application (IND) to conduct a pivotal Phase 3 ... in nontuberculous mycobacteria (NTM) lung infections has been ...   In 2010, Insmed initially submitted a ...
... (LSE: SHP, Nasdaq: SHPGY ), the global ... alfa) in patients with Fabry disease, and VPRIV® (velaglucerase ... disease, at the 2011 American College of Medical Genetics, ... from March 16-20, 2011.   Data from ...
... 2011 Recent events in Japan have caused the ... radiation can be a cause for concern – especially ... targets rapidly proliferating cells of the body. Cells of ... tract are two such cell types. Damage to these ...
Cached Biology Technology:Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication 2Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication 3Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication 4Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication 5Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection) 2Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection) 3Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection) 4Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection) 5Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change! 2Existing Radiation Countermeasures Inadequate! Development of Rx100 Promises Change! 3
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... 2015 Fingerprint Cards has received an ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... used by smartphone manufacturers in Asia . ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... is not coming from the biotech industry or ... children,s hospital. Nationwide Children,s Hospital in Columbus, ... have partnered to create BioLinQ, a new biomedical ... for disease diagnosis and medical research. "Years ...
... - People tend to think of ozone as something ... from UV radiation. At the ground level, however, ozone ... Lisa Ainsworth, a University of Illinois associate professor of ... biologist, said that establishing the exposure threshold for damage ...
... with partners In2Tec Ltd (UK) and Gwent Electronic Materials Ltd, ... be easily separated by immersion in hot water. The work ... government,s Technology Strategy Board. The Challenge ... 100 million electronic units are discarded annually in the UK ...
Cached Biology News:NCH partners with Silicon Valley to market high-end diagnostic and medical research software 2Ozone's impact on soybean yield: Reducing future losses 2Ozone's impact on soybean yield: Reducing future losses 3
Request Info...
Incorporating the innovative InGaAs detection system the Cary 6000i is the worlds most advanced UV-Vis-NIR spectrophotometer delivering superior signal to noise performance and outstanding sensitivit...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Biology Products: